battle of glp-1 delivery technologies Advances in receptor agonists systems for obesity and diabetes The Multifaceted Nature of GLP-1:

This work was partially supported by National Natural Science Foundation of China 81872915 (M.-W.W.), 82073904 (M.-W.W.), 32071203 (L.H.Z), 81922071 (Y.Z.), 81773792 (D.Y.), 81973373 (D.Y.) and 21704064 (Q.T.Z.)

Retatrutide has been studied in relation to GLP-1R signaling, receptor selectivity, and downstream biological models

DOI: 10.1136/ard-2023-223845 [Google Scholar] Cull M

Modified DPP-4 can not only mask the enzymatic hydrolysis site of DPP-4 but also bind closely with albumin to reduce renal excretion and prolong the half-life

For residual disease prediction, blue and red indicate low and high values for biomarker candidate proteins, respectively